Mechanisms of apoptosis by c-Myc

Much recent research on c-Myc has focused on how it drives apoptosis. c-Myc is widely known as a crucial regulator of cell proliferation in normal and neoplastic cells, but until relatively recently its apoptotic properties, which appear to be intrinsic, were not fully appreciated. Its death-dealing aspects have gained wide attention in part because of their potential therapeutic utility in advanced malignancy, where c-Myc is frequently deregulated and where novel modalities are badly needed. Although its exact function remains obscure, c-Myc is a transcription factor and advances have been made in characterizing target genes which may mediate its apoptotic properties. Candidate regulators and effectors are also emerging. Among recent findings are connections to the CD95/Fas and TNF pathways and roles for the tumor suppressor p19ARF and the c-Myc-interacting adaptor protein Bin1 in mediating cell death. In this review I summarize the data establishing a role for c-Myc in apoptosis in diverse settings and present a modified dual signal model for c-Myc function. It is proposed that c-Myc induces apoptosis through separate `death priming' and `death triggering' mechanisms in which `death priming' and mitogenic signals are coordinated. Investigation of the mechanisms that underlie the triggering steps may offer new therapeutic opportunities.

[1]  P. Leder,et al.  An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. , 1992, Genes & development.

[2]  S. Laster,et al.  Bleb formation and F‐actin distribution during mitosis and tumor necrosis factor‐induced apoptosis , 1996, Microscopy research and technique.

[3]  A. Bergh,et al.  Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat. , 1994, Cancer research.

[4]  M. Raffeld,et al.  A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain , 1995, Molecular and cellular biology.

[5]  Takako Onishi,et al.  AMY‐1, a novel C‐MYC binding protein that stimulates transcription activity of C‐MYC , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[6]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[7]  G. Evan,et al.  Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation , 1997, The EMBO journal.

[8]  J. Bartek,et al.  Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc , 1997, Oncogene.

[9]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[10]  S. Goff,et al.  Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation , 1997, Oncogene.

[11]  A. Nienhuis,et al.  An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation , 1988, Molecular and cellular biology.

[12]  A. Porter,et al.  Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis , 1996, Molecular and cellular biology.

[13]  Y. Lazebnik,et al.  Oncogene-dependent apoptosis in extracts from drug-resistant cells. , 1997, Genes & development.

[14]  G. Evan,et al.  Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. , 1995, Circulation research.

[15]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[16]  M. Aigle,et al.  Yeast mutant affected for viability upon nutrient starvation: Characterization and cloning of the RVS161 gene , 1991, Yeast.

[17]  T. Tsuruo,et al.  c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells , 1997, Oncogene.

[18]  G. Evan,et al.  Oncogenes and cell death. , 1994, Current opinion in genetics & development.

[19]  Seamus J. Martin,et al.  Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.

[20]  L. Williams,et al.  A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Sherr,et al.  Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.

[22]  G. Mcmahon,et al.  Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  D. Bergstrom,et al.  Participation of cyclin A in Myc-induced apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Dang,et al.  Binding and suppression of the Myc transcriptional activation domain by p107. , 1994, Science.

[25]  R. Roeder,et al.  An alternative pathway for transcription initiation involving TFII-I , 1993, Nature.

[26]  L. M. Facchini,et al.  Dysfunction of the Myc-induced apoptosis mechanism accompanies c-myc activation in the tumorigenic L929 cell line. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[27]  J. Greene,et al.  Activation and repression of mammalian gene expression by the c-myc protein. , 1987, Genes & development.

[28]  M. Aigle,et al.  Genetic and functional relationship between Rvsp, myosin and actin in Saccharomyces cerevisiae , 1998, Current Genetics.

[29]  P. Farnham,et al.  c-Myc target gene specificity is determined by a post-DNAbinding mechanism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Graeber,et al.  Modulation of c-Myc activity and apoptosis in vivo. , 1996, Cancer research.

[31]  J. Sedivy,et al.  Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. , 1998, Genes & development.

[32]  G. Evan,et al.  p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice , 1998, Current Biology.

[33]  D. Beach,et al.  Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.

[34]  B. Amati,et al.  Myc and the cell cycle. , 1998, Frontiers in bioscience : a journal and virtual library.

[35]  M. Hengstschläger,et al.  Deregulated expression of CDK2- or CDK3-associated kinase activities enhances c-Myc-induced apoptosis. , 1998, DNA and cell biology.

[36]  J. Ashwell,et al.  Cyclosporin A-Sensitive Transcription Factor Egr-3 Regulates Fas Ligand Expression , 1998, Molecular and Cellular Biology.

[37]  Francesco Cecconi,et al.  Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development , 1998, Cell.

[38]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. McPherson,et al.  Multiple Amphiphysin II Splice Variants Display Differential Clathrin Binding: Identification of Two Distinct Clathrin‐Binding Sites , 1998, Journal of neurochemistry.

[40]  R. Eisenman,et al.  Transcriptional activities of the Myc and Max proteins in mammalian cells. , 1992, Current topics in microbiology and immunology.

[41]  D. Spandidos,et al.  Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. , 1987, British Journal of Cancer.

[42]  G. Núñez,et al.  WD-40 Repeat Region Regulates Apaf-1 Self-association and Procaspase-9 Activation* , 1998, The Journal of Biological Chemistry.

[43]  H. Hermeking,et al.  Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Pagano,et al.  Differential modulation of cyclin gene expression by MYC. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Eric Wickstrom,et al.  A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.

[46]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[47]  M. Schwartz,et al.  Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  U. Siebenlist,et al.  The regulation and expression of c-myc in normal and malignant cells. , 1986, Annual review of immunology.

[49]  P. De Camilli,et al.  A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  E. Prochownik,et al.  Distinct Roles for MAX Protein Isoforms in Proliferation and Apoptosis* , 1997, The Journal of Biological Chemistry.

[51]  C. Y. Wang,et al.  Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. , 1997, Science.

[52]  L. Andersson,et al.  Ornithine decarboxylase activity is critical for cell transformation , 1992, Nature.

[53]  P. Scheurich,et al.  Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction , 1998, Current Biology.

[54]  H. Ding,et al.  Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System* , 1998, The Journal of Biological Chemistry.

[55]  D. Chao,et al.  BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.

[56]  John R. Yates,et al.  Tra1p Is a Component of the Yeast Ada·Spt Transcriptional Regulatory Complexes* , 1998, The Journal of Biological Chemistry.

[57]  K. Miyazono,et al.  ASK1 is essential for JNK/SAPK activation by TRAF2. , 1998, Molecular cell.

[58]  H. Varmus,et al.  Definition of regions in human c-myc that are involved in transformation and nuclear localization , 1987, Molecular and cellular biology.

[59]  C. Rudolph,et al.  Accelerated proliferative senescence of rat embryo fibroblasts after stable transfection of multiple copies of the c-Myc DNA-binding sequence. , 1998, Experimental cell research.

[60]  J. Cleveland,et al.  A role for c-myc in chemically induced renal-cell death , 1997, Molecular and cellular biology.

[61]  D. Sterner,et al.  The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes. , 1998, Trends in cell biology.

[62]  K. Alitalo,et al.  c‐Myc induces cellular susceptibility to the cytotoxic action of TNF‐alpha. , 1994, The EMBO journal.

[63]  M. Peter,et al.  Advances in apoptosis research. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Lotem,et al.  A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[65]  C. Sawyers,et al.  Dominant negative MYC blocks transformation by ABL oncogenes , 1992, Cell.

[66]  F M Watt,et al.  c-Myc promotes differentiation of human epidermal stem cells. , 1997, Genes & development.

[67]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[68]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[69]  G. Evan,et al.  Inhibition of Ced-3/ICE-related Proteases Does Not Prevent Cell Death Induced by Oncogenes, DNA Damage, or the Bcl-2 Homologue Bak , 1997, The Journal of cell biology.

[70]  Kristina D. Micheva,et al.  Identification and Characterization of a Nerve Terminal-enriched Amphiphysin Isoform* , 1997, The Journal of Biological Chemistry.

[71]  John Calvin Reed,et al.  Bcl-2 family proteins and mitochondria. , 1998, Biochimica et biophysica acta.

[72]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[73]  G. Evan,et al.  The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis , 1998, Oncogene.

[74]  G. Stark,et al.  MYC Abrogates p53-Mediated Cell Cycle Arrest in N-(Phosphonacetyl)-l-Aspartate-Treated Cells, Permitting CAD Gene Amplification , 1998, Molecular and Cellular Biology.

[75]  J. Sedivy,et al.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[76]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[77]  E. Dropcho Antiamphiphysin antibodies with small‐cell lung carcinoma and paraneoplastic encephalomyelitis , 1996, Annals of neurology.

[78]  A. Tokunaga,et al.  cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants. , 1997, Biochemical and biophysical research communications.

[79]  D. Ganem,et al.  Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II , 1996, Journal of virology.

[80]  J. Cheng,et al.  Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas , 1998, Molecular carcinogenesis.

[81]  C. Dang,et al.  A link between c-Myc-mediated transcriptional repression and neoplastic transformation. , 1996, The Journal of clinical investigation.

[82]  M. Cole,et al.  The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.

[83]  D. Clemmons,et al.  Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells , 1998 .

[84]  W. Ansorge,et al.  Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. , 1996, The EMBO journal.

[85]  M. Arsura,et al.  Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells , 1996, Molecular and cellular biology.

[86]  R. Johnston,et al.  Quiescence versus apoptosis: Myc abundance determines pathway of exit from the cell cycle , 1998, Oncogene.

[87]  A. Giaccia,et al.  Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. , 1998, Cancer research.

[88]  C. Ascoli,et al.  Identification of a novel nuclear domain , 1991, The Journal of cell biology.

[89]  M. Czaja,et al.  c‐myc‐dependent hepatoma cell apoptosis results from oxidative stress and not a deficiency of growth factors , 1997, Journal of cellular physiology.

[90]  R. Eisenman,et al.  Myc target genes. , 1997, Trends in biochemical sciences.

[91]  M. Czech,et al.  Stimulation of IRS-1-associated Phosphatidylinositol 3-Kinase and Akt/Protein Kinase B but Not Glucose Transport by β1-Integrin Signaling in Rat Adipocytes* , 1998, The Journal of Biological Chemistry.

[92]  P. Camilli,et al.  Amphiphysin II (SH3P9; BIN1), a Member of the Amphiphysin/Rvs Family, Is Concentrated in the Cortical Cytomatrix of Axon Initial Segments and Nodes of Ranvier in Brain and around T Tubules in Skeletal Muscle , 1997, The Journal of cell biology.

[93]  G. Evan,et al.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max , 1992, Nature.

[94]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[95]  P. De Camilli,et al.  Autoimmunity in Stiff‐Man Syndrome with breast cancer is targeted to the C‐terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161 , 1994, FEBS letters.

[96]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[97]  D. Goeddel,et al.  Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. , 1997, Immunity.

[98]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[99]  E. Prochownik,et al.  Differential patterns of DNA binding by myc and max proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[100]  C. Kumar,et al.  Signaling by integrin receptors , 1998, Oncogene.

[101]  D. McDonald,et al.  Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[102]  G. Prendergast,et al.  c‐Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. , 1994, The EMBO journal.

[103]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[104]  Robert Wechsler-Reya,et al.  BIN1 is a novel MYC–interacting protein with features of a tumour suppressor , 1996, Nature Genetics.

[105]  J. Cleveland,et al.  v-Raf/v-Myc synergism in abrogation of IL-3 dependence: v-Raf suppresses apoptosis. , 1992, Current topics in microbiology and immunology.

[106]  M. Scheid,et al.  Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Jean-Claude Martinou,et al.  Bax-induced Cytochrome C Release from Mitochondria Is Independent of the Permeability Transition Pore but Highly Dependent on Mg2+ Ions , 1998, The Journal of cell biology.

[108]  A. Pendergast,et al.  The amphiphysin-like protein 1 (ALP1) interacts functionally with the cABL tyrosine kinase and may play a role in cytoskeletal regulation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[109]  P. Watson,et al.  Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. , 1993, Journal of the National Cancer Institute.

[110]  K. Ryan,et al.  Cell-cycle progression is not essential for c-Myc to block differentiation , 1997, Oncogene.

[111]  D. Green Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[112]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[113]  D. Baltimore,et al.  Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. , 1998, Science.

[114]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[115]  S. Chen,et al.  Diva, a Bcl-2 Homologue that Binds Directly to Apaf-1 and Induces BH3-independent Cell Death* , 1998, The Journal of Biological Chemistry.

[116]  G. Prendergast,et al.  The polyproline region of p53 is required to activate apoptosis but not growth arrest , 1997, Oncogene.

[117]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[118]  Didier Picard,et al.  Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.

[119]  A. Giaccia,et al.  Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis , 1997, Molecular and cellular biology.

[120]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[121]  K. Alitalo,et al.  Repression of cyclin D1: a novel function of MYC. , 1994, Molecular and cellular biology.

[122]  D. Green,et al.  DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.

[123]  John Calvin Reed,et al.  The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. , 1994, Molecular and cellular biology.

[124]  H. McMahon,et al.  Inhibition of receptor-mediated endocytosis by the amphiphysin SH3 domain , 1997, Current Biology.

[125]  N. Kyprianou,et al.  Therapeutic Approaches to Activating Programmed Cell Death of Androgen-Independent Prostatic Cancer Cells , 1991 .

[126]  Yufang Shi,et al.  Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression , 1998, Oncogene.

[127]  Gwyn T. Williams Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.

[128]  M. Rose,et al.  Rvs161p Interacts with Fus2p to Promote Cell Fusion in Saccharomyces cerevisiae , 1998, The Journal of cell biology.

[129]  M. Méchali,et al.  c-Myc in the control of cell proliferation and embryonic development. , 1996, Advances in cancer research.

[130]  J. Parsons,et al.  Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. , 1997, Current opinion in cell biology.

[131]  V. Dixit,et al.  Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex* , 1998, The Journal of Biological Chemistry.

[132]  S. Lowe,et al.  E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.

[133]  G. Prendergast,et al.  Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation , 1991, Cell.

[134]  R. Eisenman,et al.  Myc and Max Homologs in Drosophila , 1996, Science.

[135]  Bruno Amati,et al.  Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.

[136]  Liang Zhu,et al.  Interaction of c‐Myc with the pRb‐related protein p107 results in inhibition of c‐Myc‐mediated transactivation. , 1994, The EMBO journal.

[137]  G. Prendergast,et al.  Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity , 1995, Molecular and cellular biology.

[138]  P. O'dwyer,et al.  Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. , 1995, Journal of the National Cancer Institute.

[139]  E. Liu,et al.  Identification of a large Myc-binding protein that contains RCC1-like repeats. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[140]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[141]  M. Aigle,et al.  Alteration of a yeast SH3 protein leads to conditional viability with defects in cytoskeletal and budding patterns , 1993, Molecular and cellular biology.

[142]  E Ruoslahti,et al.  Integrins and anoikis. , 1997, Current opinion in cell biology.

[143]  K. Klempnauer,et al.  Sequence-specific DNA binding by Myc proteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[144]  D. Brough,et al.  An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation , 1995, Molecular and cellular biology.

[145]  P. Farnham,et al.  An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants , 1995, Molecular and cellular biology.

[146]  Asim Khwaja,et al.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.

[147]  L. Peso,et al.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.

[148]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[149]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.

[150]  D. Fisher,et al.  Loss of Matrix Adhesion Triggers Rapid Transformation-Selective Apoptosis in Fibroblasts , 1997, The Journal of cell biology.

[151]  M. Cole,et al.  c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. , 1998, Genes & development.

[152]  D. Hehir,et al.  C‐myc oncogene expression: A marker for females at risk of breast carcinoma , 1993, Journal of surgical oncology.

[153]  J P Luzio,et al.  Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.

[154]  K. Zerres,et al.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. , 1997, Genes & development.

[155]  M. Schwab,et al.  MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells , 1998, Oncogene.

[156]  D. Green,et al.  Regulation of Fas-Ligand Expression during Activation-induced Cell Death in T Lymphocytes via Nuclear Factor κB* , 1999, The Journal of Biological Chemistry.

[157]  J. Cleveland,et al.  Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways , 1997, Oncogene.

[158]  Richard O. Hynes,et al.  Integrin-mediated Signals Regulated by Members of the Rho Family of GTPases , 1998, The Journal of cell biology.

[159]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[160]  K. Alitalo,et al.  Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras Cotransformation , 1992, Science.

[161]  J. Foekens,et al.  Receptors for hormones and growth factors and (ONCO)‐gene amplification in human ovarian cancer , 1992, International journal of cancer.

[162]  W. Gu,et al.  Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[163]  G. Evan,et al.  Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. , 1997, Science.

[164]  J. Sedivy,et al.  Effects of c-myc expression on cell cycle progression , 1994, Molecular and cellular biology.

[165]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[166]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[167]  J. Cleveland,et al.  c-Myc and apoptosis. , 1995, Biochimica et biophysica acta.

[168]  K. Bhatia,et al.  A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[169]  H. Hermeking,et al.  Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.

[170]  L. Williams,et al.  Tumor necrosis factor α‐induced activation of c‐jun N‐terminal kinase is mediated by TRAF2 , 1997, The EMBO journal.

[171]  N. Kyprianou,et al.  Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. , 1990, Cancer research.

[172]  E. Prochownik,et al.  Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[173]  A. Wyllie,et al.  Apoptosis (the 1992 Frank Rose Memorial Lecture). , 1993, British Journal of Cancer.

[174]  R. Eisenman,et al.  Myc and Max associate in vivo. , 1992, Genes & development.

[175]  G. Evan,et al.  The role of c-myc in cell growth. , 1993, Current opinion in genetics & development.

[176]  M. Cole The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.

[177]  C. Dang,et al.  A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[178]  Jacques Landry,et al.  SAPK2/p38-dependent F-Actin Reorganization Regulates Early Membrane Blebbing during Stress-induced Apoptosis , 1998, The Journal of cell biology.

[179]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[180]  L. M. Facchini,et al.  The molecular role of Myc in growth and transformation: recent discoveries lead to new insights , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[181]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[182]  G. Prendergast,et al.  A Role for the Putative Tumor Suppressor Bin1 in Muscle Cell Differentiation , 1998, Molecular and Cellular Biology.

[183]  R. DePinho,et al.  Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[184]  F. Kaye,et al.  The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro , 1995, Molecular and cellular biology.

[185]  T. Mak,et al.  Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development , 1998, Cell.

[186]  A. Levine The tumor suppressor genes. , 1993, Annual review of biochemistry.

[187]  C. Thompson,et al.  Bcl-2-family proteins: the role of the BH3 domain in apoptosis. , 1998, Trends in cell biology.

[188]  G. Prendergast,et al.  Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. , 1992, Genes & development.

[189]  D. Thorley-Lawson,et al.  A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.

[190]  J Downward,et al.  Ras signalling and apoptosis. , 1998, Current opinion in genetics & development.

[191]  D. Bostwick,et al.  Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.

[192]  D. Slamon,et al.  Proto-oncogenes and tumor suppressor genes in human urological malignancies. , 1994, The Journal of urology.

[193]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[194]  G. Prendergast,et al.  Structural Analysis of the Human BIN1 Gene , 1997, The Journal of Biological Chemistry.

[195]  G. Koretzky,et al.  Stress-Induced Fas Ligand Expression in T Cells Is Mediated through a MEK Kinase 1-Regulated Response Element in the Fas Ligand Promoter , 1998, Molecular and Cellular Biology.

[196]  R. Johnston,et al.  Apoptosis induced by c-myc overexpression is dependent on growth conditions. , 1995, Experimental cell research.

[197]  A. Porter,et al.  Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells , 1994, Molecular and cellular biology.

[198]  G. Evan,et al.  Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis , 1997, Molecular and cellular biology.

[199]  C. Dang,et al.  Max: functional domains and interaction with c-Myc. , 1992, Genes & development.

[200]  K. Ryan,et al.  Myc oncogenes: the enigmatic family. , 1996, The Biochemical journal.

[201]  Y. Lazebnik,et al.  Oncogene-dependent apoptosis is mediated by caspase-9. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[202]  R. DePinho,et al.  Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. , 1992, Genes & development.

[203]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[204]  M. Aigle,et al.  Cloning of the Multicopy Suppressor Gene SUR7: Evidence for a Functional Relationship between the Yeast Actin‐binding Protein Rvs167 and a Putative Membranous Protein , 1998, Yeast.

[205]  M. Eilers,et al.  Control of cell proliferation by Myc. , 1998, Trends in cell biology.

[206]  G. Evan,et al.  Apoptosis and the cell cycle. , 1995, Current opinion in cell biology.

[207]  M. Herlyn,et al.  The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. , 1997, Cancer research.

[208]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[209]  K. Noguchi,et al.  A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis , 1997, Molecular and cellular biology.

[210]  G. Evan,et al.  A matter of life and cell death. , 1998, Science.

[211]  G. Prendergast Myc Structure and Function , 1997 .

[212]  M. Welsh,et al.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells , 1991, Molecular and cellular biology.

[213]  Stephen K. Burley,et al.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.

[214]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[215]  J. Yuan,et al.  Evolutionary conservation of a genetic pathway of programmed cell death , 1996, Journal of cellular biochemistry.

[216]  M. Fernö,et al.  c‐myc amplification is an independent prognostic factor in postmenopausal breast cancer , 1992, International journal of cancer.

[217]  M. Cole,et al.  Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. , 1992, Genes & development.

[218]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[219]  S. Lowe,et al.  Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. , 1998, Genes & development.

[220]  J. Frost,et al.  c-Myc cooperates with activated Ras to induce the cdc2 promoter , 1994, Molecular and cellular biology.

[221]  S Gaubatz,et al.  An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc , 1994, Molecular and cellular biology.

[222]  G. Evan,et al.  The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.

[223]  P. Pandolfi,et al.  Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.

[224]  H. McMahon,et al.  Crystal structure of the amphiphysin‐2 SH3 domain and its role in the prevention of dynamin ring formation , 1998, The EMBO journal.

[225]  J. Cleveland,et al.  Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis , 1994, Molecular and cellular biology.

[226]  N. Hay,et al.  Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.

[227]  H. Horvitz,et al.  Genetics of programmed cell death in C. elegans: past, present and future. , 1998, Trends in genetics : TIG.

[228]  V. Rotter,et al.  c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[229]  J A Moshier,et al.  Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. , 1993, Cancer research.

[230]  D. Green,et al.  Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. , 1992, Science.

[231]  H. Horvitz,et al.  Mechanisms and functions of cell death. , 1991, Annual review of cell biology.

[232]  T. Halazonetis,et al.  Determination of the c-MYC DNA-binding site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[233]  I. Garkavtsev,et al.  A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. , 1997, Cancer research.

[234]  H. Weintraub,et al.  Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.

[235]  B. de Crombrugghe,et al.  Transcriptional suppression of cellular gene expression by c-Myc , 1991, Molecular and cellular biology.

[236]  J. Brugge,et al.  Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation , 1997, Molecular and cellular biology.

[237]  A. Fornace,et al.  Myc represses the growth arrest gene gadd45 , 1997, Oncogene.

[238]  R. Perry,et al.  Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. , 1996, Journal of the National Cancer Institute.

[239]  H. Perlman,et al.  Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. , 1995, Cancer research.

[240]  L. Shantz,et al.  Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. , 1994, Cancer research.

[241]  N. Rosen,et al.  Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway* , 1998, The Journal of Biological Chemistry.

[242]  P. Watson,et al.  c-myc oncogene expression in estrogen-dependent and -independent breast cancer. , 1993, Clinical chemistry.

[243]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[244]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[245]  M. Groudine,et al.  Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.

[246]  E. Hölttä,et al.  Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis , 1998, Oncogene.

[247]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[248]  D. Soprano,et al.  Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. , 1996, Oncogene.

[249]  G. Prendergast,et al.  Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. , 1991, Science.

[250]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[251]  M. Barone,et al.  Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src , 1995, Nature.

[252]  D. Litchfield,et al.  Rescue from granzyme B-induced apoptosis by Wee1 kinase , 1995, The Journal of experimental medicine.

[253]  O. Yanuka,et al.  Involvement of Myc targets in c-myc and N-myc induced human tumors , 1998, Oncogene.

[254]  D. Green,et al.  Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.

[255]  G. Evan,et al.  Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.

[256]  C. Ling,et al.  Apoptosis in heat-induced cell killing: the protective role of hsp-70 and the sensitization effect of the c-myc gene. , 1996, Radiation research.

[257]  M. Hung,et al.  c-myc reverses neu-induced transformed morphology by transcriptional repression , 1991, Molecular and cellular biology.

[258]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[259]  M. Schwab,et al.  The N‐Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. , 1991, The EMBO journal.

[260]  G. Evan,et al.  c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.

[261]  Lianfa Shi,et al.  Premature p34cdc2 activation required for apoptosis. , 1994, Science.

[262]  Brian J. Stevenson,et al.  end5, end6, and end7: mutations that cause actin delocalization and block the internalization step of endocytosis in Saccharomyces cerevisiae. , 1995, Molecular biology of the cell.

[263]  G. Natoli,et al.  Activation of SAPK/JNK by TNF Receptor 1 Through a Noncytotoxic TRAF2-Dependent Pathway , 1997, Science.

[264]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[265]  M. Linial,et al.  Viral Myc Oncoproteins in Infected Fibroblasts Down-modulate Thrombospondin-1, a Possible Tumor Suppressor Gene* , 1996, The Journal of Biological Chemistry.

[266]  V. D’Agati,et al.  C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent , 1997, The Journal of experimental medicine.

[267]  M. Koken,et al.  PML induces a novel caspase-independent death process , 1998, Nature Genetics.

[268]  N. Kabra,et al.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.

[269]  C. Sawyers,et al.  The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.